dc.creatorGesivaldo Santos
dc.creatorLisandro Diego Giraldez-Alvarez
dc.creatorMarco Ávila-Rodriguez
dc.creatorFrancisco Capani
dc.creatorEduardo Galembeck
dc.creatorAristóteles Góes Neto
dc.creatorGeorge E. Barreto
dc.creatorBruno Andrade
dc.date.accessioned2023-06-15T21:26:53Z
dc.date.accessioned2023-06-16T16:41:15Z
dc.date.available2023-06-15T21:26:53Z
dc.date.available2023-06-16T16:41:15Z
dc.date.created2023-06-15T21:26:53Z
dc.date.issued2016
dc.identifierhttps://doi.org/10.3389/fnagi.2016.00097
dc.identifier1663-4365
dc.identifierhttp://hdl.handle.net/1843/54979
dc.identifierhttps://orcid.org/0000-0001-8218-0292
dc.identifierhttps://orcid.org/0000-0003-4612-3236
dc.identifierhttps://orcid.org/0000-0003-0342-0628
dc.identifierhttps://orcid.org/0000-0003-4238-5546
dc.identifierhttps://orcid.org/0000-0002-7692-6243
dc.identifierhttps://orcid.org/0000-0002-6644-1971
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6683214
dc.publisherUniversidade Federal de Minas Gerais
dc.publisherBrasil
dc.publisherICB - DEPARTAMENTO DE MICROBIOLOGIA
dc.publisherUFMG
dc.relationFrontiers in Aging Neuroscience
dc.rightsAcesso Aberto
dc.subjectValeriana officinalis
dc.subjectParkinson disease
dc.subjectNeuroprotection
dc.subjectSUR1
dc.subjectGABAA
dc.titleSUR1 receptor interaction with hesperidin and linarin predicts possible mechanisms of action of Valeriana officinalis in Parkinson
dc.typeArtigo de Periódico


Este ítem pertenece a la siguiente institución